tiprankstipranks
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market

Dr. Reddy's Laboratories Ltd. (DRREDDY) Financial Statements

Compare
0 Followers

Dr. Reddy's Laboratories Ltd. Financial Overview

Dr. Reddy's Laboratories Ltd.'s market cap is currently ₹932.16B. The company's EPS TTM is ₹64.396; its P/E ratio is 17.36; and it has a dividend yield of 0.71%. Dr. Reddy's Laboratories Ltd. is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is ₹18.27. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 279.16B₹ 245.88B₹ 214.39B₹ 189.72B₹ 174.60B
Gross Profit₹ 163.61B₹ 169.30B₹ 113.84B₹ 103.08B₹ 94.01B
Operating Income₹ 67.73B₹ 57.14B₹ 29.48B₹ 26.19B₹ 15.99B
EBITDA₹ 88.28B₹ 74.06B₹ 47.74B₹ 45.71B₹ 41.78B
Net Income₹ 55.68B₹ 45.07B₹ 23.57B₹ 17.24B₹ 19.50B
Balance Sheet
Cash & Short-Term Investments₹ 81.47B₹ 66.75B₹ 44.37B₹ 34.57B₹ 25.74B
Total Assets₹ 387.52B₹ 322.85B₹ 296.65B₹ 265.49B₹ 232.24B
Total Debt₹ 20.02B₹ 13.47B₹ 33.84B₹ 30.31B₹ 22.10B
Net Debt₹ 12.91B₹ 7.69B₹ 18.99B₹ 15.48B₹ 20.05B
Total Liabilities₹ 106.97B₹ 89.99B₹ 106.13B₹ 90.51B₹ 77.25B
Stockholders' Equity₹ 280.55B₹ 232.86B₹ 190.53B₹ 174.98B₹ 154.99B
Cash Flow
Free Cash Flow₹ 18.00B₹ 40.01B₹ 9.06B₹ 23.14B₹ 23.73B
Operating Cash Flow₹ 45.43B₹ 58.87B₹ 28.11B₹ 35.70B₹ 29.84B
Investing Cash Flow₹ -40.28B₹ -41.37B₹ -26.39B₹ -22.66B₹ -4.92B
Financing Cash Flow₹ -3.76B₹ -26.86B₹ -2.42B₹ -298.00M₹ -25.16B
Currency in INR

Dr. Reddy's Laboratories Ltd. Earnings and Revenue History

Dr. Reddy's Laboratories Ltd. Debt to Assets

Dr. Reddy's Laboratories Ltd. Cash Flow

Dr. Reddy's Laboratories Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis